Plazomicin Nitroso Impurity 1
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Plazomicin is a parenterally administered, broad spectrum aminoglycoside antibiotic typically used for moderate-to-severe urinary tract infections or pyelonephritis.Plazomicin Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Plazomicin Nitroso Impurity 1 CAS NO:NA Chemically represented as (S)-4-amino-N-((1R,2S,3S,4R,5S)-5-amino-4-(((2S,3R)-3-amino-6-(((2-hydroxyethyl)amino)methyl)-3,4-dihydro-2H-pyran-2-yl)oxy)-2-(((2R,3R,4R,5R)-3,5-dihydroxy-5-methyl-4-(methyl(nitroso)amino)tetrahydro-2H-pyran-2-yl)oxy)-3-hydroxycyclohexyl)-2-hydroxybutanamide. Synchemia is the leading manufacturing and exporter of Plazomicin Nitroso Impurity 1. We supply Plazomicin Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142163 |
| CAS No | NA |
| Mol.F. | C10H12N2O4 |
| Mol.Wt. | 224.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142164 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142165 |
| CAS No | NA |
| Mol.F. | C23H22ClFN6O4 |
| Mol.Wt. | 500.9 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142166 |
| CAS No | NA |
| Mol.F. | C24H24ClFN6O4 |
| Mol.Wt. | 514.94 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142167 |
| CAS No | NA |
| Mol.F. | C23H22F2N6O4 |
| Mol.Wt. | 484.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142168 |
| CAS No | NA |
| Mol.F. | C25H27F2N9O |
| Mol.Wt. | 507.55 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142169 |
| CAS No | NA |
| Mol.F. | C18H13ClFN5O5 |
| Mol.Wt. | 433.78 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142170 |
| CAS No | NA |
| Mol.F. | C18H15ClFN5O3 |
| Mol.Wt. | 403.8 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142171 |
| CAS No | NA |
| Mol.F. | C17H19N5O5 |
| Mol.Wt. | 373.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142172 |
| CAS No | NA |
| Mol.F. | C21H20ClFN6O3 |
| Mol.Wt. | 458.88 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142173 |
| CAS No | NA |
| Mol.F. | C27H26ClFN6O8 |
| Mol.Wt. | 616.99 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142174 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S |
| Mol.Wt. | 336.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142175 |
| CAS No | NA |
| Mol.F. | C15H16N2O3 |
| Mol.Wt. | 272.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142176 |
| CAS No | NA |
| Mol.F. | C26H26N2O3 |
| Mol.Wt. | 414.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142177 |
| CAS No | NA |
| Mol.F. | C15H18N2O3 |
| Mol.Wt. | 274.32 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142178 |
| CAS No | NA |
| Mol.F. | C14H14N2O3 |
| Mol.Wt. | 258.28 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |